Skip to main content

Market Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

[Business Wire] – Alexion Pharmaceuticals, Inc. today announced that management will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Tuesday, May 10, 2016 at 10:40 a.m., Pacific Time. Read more on this. Alexion Pharmaceuticals, Inc. (ALXN) , currently valued at $31.87B, opened at $143.70. A quick look at the market, the company’s stock traded between $140.87 and $144.46 and has traded between $124.16 and $208.88 over the past year. ALXN shares are currently priced at 28.59x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -6.99x earnings multiple for the same period. According to a consensus of 21 analysts, the earnings estimate of $1.18 per share would be $0.26 worse than the year-ago quarter and a $0.07 sequential decrease. The full-year EPS estimate is $5.05 which would be a $0.06 better than last year’s full-year earnings. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $742.09 Million. If realized, that would be a 16.64% increase over the year-ago quarter. In terms of ratings, Robert W. Baird downgraded ALXN from Outperform to Neutral (Mar 8, 2016). Previously, Citigroup Initiated ALXN at to Buy. Investors should keep in mind is that the average price target is $195.74, which is 36.21% above where the stock opened this morning. See more in (NASDAQ:ALXN) Similar Articles: Market Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report First Quarter 2016 Results on Thursday, April 28, 2016 Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion to Present at the Leerink Partners 5th Annual Global Healthcare Conference Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2015 Results on Wednesday, February 3, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.